Featured News Stories
Vizient Offers Comments to FDA on List of Essential Medicines, Medical Countermeasures and Critical Inputs
Vizient Announces Novaplus Enhanced Supply Agreement with Pfizer for 7 Additional Essential Medications
In the news
Vizient analysis shows ending unapproved drugs initiative could save between $7.52 billion and $26.59 billion
The difference in charges for identical services depending on the source of payment is difficult for patients to understand, and even more difficult for providers to explain. With more intense scrutiny on private sector prices arising from higher insurance deductibles and enthusiasm by policymakers over transparency, it is hard to ignore.
The COVID-19 pandemic has led to unprecedented changes for health care systems. We're here to offer the resources and tools to help guide your hospital through this crisis.